To place an order forProteomics: Technologiesand Global Marketscall 866-285-7215May 2013Report ID: BIO034C
The key objective was to present a comprehensive discussion of the main commercialproteomic technologies, along with the current and future commercial potential foreach of the key market segments.
REASONS FOR DOING THE STUDY
BCC Research has previously examined the proteomic industry as part of several largerstudies. For example, BCC published a report on biochips in 2011 that covered proteinarrays and lab-on-a-chip (LOAC) products and markets. In 2010, BCC published areport on next-generation cancer diagnostics that covered diagnostics applications forproteomic biochips. The main objective for the present report is to present the up-to-date market picturefor proteomics into a single comprehensive report. The objective was to capture thechanging industry dynamics and market shift occurring in this industry. Thus, it istimely to examine the key aspects of the proteomic industry. There is also an urgent need in the life science industry for technologies and productsthat can analyze and study the human proteome in a high-throughput, multiplex andlow-cost way. Proteomic technologies are evolving to meet more of these needs, so itis important to keep abreast of these dynamics. This report is intended to inform companies in the life science industries regarding theimportant trends in MS, LOAC and arrays, as well as to provide detailed informationconcerning the individual market segments and industry dynamics.
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
BCC has compiled a study of critical proteomic technologies that are used in the fourmajor end-user segments: research, drug discovery and development, diagnostics andapplied markets. The report discusses the proteomic platforms, market growth drivingforces, product types, key market applications, companies and alliances, industrydynamics, patents, future market potential and product sales forecasts for the periodfrom 2012 through 2017. This study will be of particular interest to the companies in such industries asdiagnostics, pharmaceuticals, biotechnology, nanotechnology, life sciences tools,biodefense, medical devices, analytical instruments, chromatography, chemicals,polymers, glass and bioinformatics. It will also be of interest to companies involved indrug, diagnostic and/or biomarker discovery programs; manufacturers of microarraysand lab-on-a-chip devices; sample prep suppliers; bioinformatics developers; andcancer researchers and clinicians.
SCOPE AND FORMAT
The study scope covers MS instruments, consumables, workflow products, planararrays, bead arrays and LOAC. It also covers the research, drug discovery anddevelopment, diagnostics and applied end-user market segments. The maingeographical markets—North America, Europe, Japan and Rest of World (ROW)—areincluded. The MS market is covered by instrument type, MS consumables, product type andend-user markets. The biochip market is covered by biochip type and the-end usermarket for each type. The diagnostics market is covered in some detail, including bymajor platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as theirforecasted growth through 2017. Technology status and market driving forces are discussed. Factors that influenceeach market are also discussed, including growth-driving forces, industry alliances andacquisitions, applications in diagnostics and drug discovery, customer needs andcompetitive trends.